Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

HealthLynked (HLYK) Shares Outstanding (2016 - 2025)

HealthLynked (HLYK) has disclosed Shares Outstanding for 10 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 2.1% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 million through Dec 2025, up 2.1% year-over-year, with the annual reading at $2.9 million for FY2025, 2.1% up from the prior year.
  • Shares Outstanding for Q4 2025 was $2.9 million at HealthLynked, up from $2.8 million in the prior quarter.
  • The five-year high for Shares Outstanding was $247.9 million in Q3 2022, with the low at $33334.0 in Q2 2022.
  • Average Shares Outstanding over 5 years is $49.4 million, with a median of $2.8 million recorded in 2024.
  • Peak annual rise in Shares Outstanding hit 8555.75% in 2022, while the deepest fall reached 99.87% in 2022.
  • Over 5 years, Shares Outstanding stood at $2.8 million in 2021, then changed by 0.0% to $2.8 million in 2022, then grew by 0.44% to $2.8 million in 2023, then increased by 2.17% to $2.8 million in 2024, then increased by 2.1% to $2.9 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $2.9 million, $2.8 million, and $2.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.